4processed
Form 4 — Insider Transaction
Krystal Biotech, Inc.(KRYS)
Filing Date
June 25, 2026
Accepted
June 25, 2026
Accession No.
0002114900-26-000009
CIK
0001711279
Insider Transactions
| Insider | Title | Type | Shares | Price | Value | Owned After | Security | Date |
|---|---|---|---|---|---|---|---|---|
| Thomas John Charles | EVP, General Counsel | Other | 1.0K | $179.25 | — | 1.0K | Common Stock | Jun 25, 2026 |
| Thomas John Charles | EVP, General Counsel | Other | 1.0K | $347.27 | — | 0 | Common Stock | Jun 25, 2026 |
| Thomas John Charles | EVP, General Counsel | Other | 1.0K | $0 | — | 6.5K | Stock Option (Right to Buy) | Jun 25, 2026 |